Luiz Fernando Bazzo Catto, MD1,2, Nidhi Aggarwal, BS3*, Ruba Shalhoub4*, Natthakan Thongon, PhD5, Tania Rene Machado, RN, BSN6*, Ivana Darden, RN7*, Jennifer Lotter, ms7, Bhavisha A. Patel, MD7, Geraldine Aubert, PhD8*, Colin O. Wu, PhD4*, Simona Colla, PhD9, Cynthia E. Dunbar, MD10, Fernanda Rodrigues, PhD11* and Emma M. Groarke, MD7
1Translational Stem Cell Biology Branch, National Heart, Lung and Blood Institute, Bethesda, MD
2Translational Stem Cell Biology Branch, National Heart, Lung and Blood Institute, Ribeirão Preto, Brazil
3Hematology Branch, National Heart, Lung and Blood Institute, Bethesda
4Office of Biostatistics Research, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD
5Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
6Office of Research Nurses, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD
7Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD
8British Columbia Cancer Agency, Vancouver, BC, CAN
9Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston
10Translational Stem Cell Biology Branch, National Heart, Lung, and Blood Institute, NHLBI/NIH, Bethesda, MD
11Hematology Branch, National Heart Lung and Blood Institutes, National Institutes of Health, Bethesda